The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013.
Publication Type
Review
Authors
O'Reilly M, Federoff H, Fong Y, Kohn D, Patterson A, Ahmed N, Asokan A, Boye S, Crystal R, De Oliveira S, Gargiulo L, Harper S, Ikeda Y, Jambou R, Montgomery M, Prograis L, Rosenthal E, Sterman D, Vandenberghe L, Zoloth L, Abedi M, Adair J, Adusumilli P, Goins W, Gray J, Monahan P, Popplewell L, Sena-Esteves M, Tannous B, Weber T, Wierda W, Gopal-Srivastava R, McDonald C, Rosenblum D, Corrigan-Curay J
Journal
Hum Gene Ther
Volume
25
Issue
6
Pagination
488-97
Date Published
06/01/2014
ISSN
1557-7422
Keywords
Genetic Therapy
Abstract
Recently, the gene therapy field has begun to experience clinical successes in a number of different diseases using various approaches and vectors. The workshop Gene Therapy: Charting a Future Course, sponsored by the National Institutes of Health (NIH) Office of Biotechnology Activities, brought together early and mid-career researchers to discuss the key scientific challenges and opportunities, ethical and communication issues, and NIH and foundation resources available to facilitate further clinical advances.